Menu Search
Equities

Generic Sweden AB (publ)

GENI:STO

Generic Sweden AB (publ)

Actions
  • Price (SEK)44.70
  • Today's Change-0.300 / -0.67%
  • Shares traded3.22k
  • 1 Year change-11.66%
  • Beta1.1388
Data delayed at least 15 minutes, as of Sep 20 2024 10:37 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in SEK

The one analyst offering a 12 month price target expects Generic Sweden AB (publ) share price to fall to 5.55 in the next year from the last price of 45.00.
High-87.7%5.55
Med-87.7%5.55
Low-87.7%5.55

Dividends

In 2023, Generic Sweden AB (publ) reported a dividend of 1.50 SEK, which represents a 20.00% increase over last year. The analyst covering the company expects dividends of 1.75 SEK for the upcoming fiscal year, an increase of 16.67%.
Div growth (TTM)20.00%
More ▼

Earnings history & estimates in SEK

On Aug 22, 2024, Generic Sweden AB (publ) reported 2nd quarter 2024 earnings of 0.44 per share.
The next earnings announcement is expected on Nov 14, 2024.
Average growth rate+1.15%
Generic Sweden AB (publ) reported annual 2023 earnings of 1.90 per share on Feb 15, 2024.
Average growth rate+29.16%
More ▼

Revenue history & estimates in SEK

Generic Sweden AB had 2nd quarter 2024 revenues of 43.41m. This bettered the 42.00m estimate of the one analyst covering the company. This was 25.32% above the prior year's 2nd quarter results.
Average growth rate+5.94%
Generic Sweden AB had revenues for the full year 2023 of 142.59m. This was 11.63% above the prior year's results.
Average growth rate+20.34%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.